It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

Meanwhile, although Ray wrote the bulk of The Kinks’ songs, Dave also regularly contributed his compositions to the band. His tunes generally received less attention than those written by his brother ...

Dave Coulier’s tongue cancer is officially in remission, two months after going public with his diagnosis. “It's been a roller-coaster ride for sure," Coulier, 66, said during a Wednesday, February 4, ...

Novo Nordisk, maker of Wegovy, saw its stock rise 6.5% after the opening bell on Monday. The company and the U.S. Food and Drug Administration threatened legal action against Hims & Hers, over its ...

WASHINGTON (AP) — A new kind of pill sharply reduced artery-clogging cholesterol in people who remain at high risk of heart attacks despite taking statins, researchers reported Wednesday. It’s still ...

Hims & Hers' decision to stop offering the $49 version of Novo Nordisk A/S' (NYSE: NVO) Wegovy comes days after the company launched it. "Since launching the compounded semaglutide pill on our ...

After weeks of sessions and hours of debate, South Carolina Representatives approved the third reading of a bill that would restrict some access to abortion-causing medications.H. 4760 is titled ...

CLEVELAND — Ohio Attorney General Dave Yost on Tuesday approved the title and summary language for Ohioans for Cannabis Choice's proposed referendum challenging the state's new recreational marijuana ...

Online telehealth company Hims & Hers stock ticked lower Friday after Novo Nordisk said its newly announced Wegovy pill copy was illegal and that it would take legal action. Hims is launching its pill ...

WASHINGTON (AP) — Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight-loss pill Wegovy, just weeks after drugmaker Novo Nordisk launched its highly ...

Novo Nordisk stock surged after Hims & Hers scrapped plans to sell a copycat version of the drugmaker’s weight-loss pill following pressure from U.S. regulators. Shares in Novo Nordisk jumped nearly 7 ...